Home

pattern Bermad volume ppms time to wheelchair Pedagogy tornado Restriction

Ocrelizumab Reduces Wheelchair Use in Primary Progressive MS
Ocrelizumab Reduces Wheelchair Use in Primary Progressive MS

Multiple Sclerosis Patient Stories - Mitch, MS Advocate - Atara  Biotherapeutics
Multiple Sclerosis Patient Stories - Mitch, MS Advocate - Atara Biotherapeutics

#ECTRIMS2019 - Early Ocrevus Use in PPMS Slows Disability, Including Risk  of Wheelchair Reliance
#ECTRIMS2019 - Early Ocrevus Use in PPMS Slows Disability, Including Risk of Wheelchair Reliance

Primary-Progressive MS: 6 Top Technology Recommendations
Primary-Progressive MS: 6 Top Technology Recommendations

Long-term follow-up from the ORATORIO trial of ocrelizumab for primary  progressive multiple sclerosis: a post-hoc analysis from the ongoing  open-label extension of the randomised, placebo-controlled, phase 3 trial -  The Lancet Neurology
Long-term follow-up from the ORATORIO trial of ocrelizumab for primary progressive multiple sclerosis: a post-hoc analysis from the ongoing open-label extension of the randomised, placebo-controlled, phase 3 trial - The Lancet Neurology

Blood Neurofilament Light in Progressive Multiple Sclerosis | Neurology
Blood Neurofilament Light in Progressive Multiple Sclerosis | Neurology

Time to, and age at, EDSS 4.0, 6.0 and 8.0 based upon Kaplan-Meier... |  Download Table
Time to, and age at, EDSS 4.0, 6.0 and 8.0 based upon Kaplan-Meier... | Download Table

My Taking My Life Back Bucket List | MS And Me Media
My Taking My Life Back Bucket List | MS And Me Media

PPMS: Prognosis and Life Expectancy | MyMSTeam
PPMS: Prognosis and Life Expectancy | MyMSTeam

Blood neurofilament light levels predict non-relapsing progression  following anti-CD20 therapy in relapsing and primary progressive multiple  sclerosis: findings from the ocrelizumab randomised, double-blind phase 3  clinical trials - eBioMedicine
Blood neurofilament light levels predict non-relapsing progression following anti-CD20 therapy in relapsing and primary progressive multiple sclerosis: findings from the ocrelizumab randomised, double-blind phase 3 clinical trials - eBioMedicine

10 Essential Facts About Primary-Progressive MS
10 Essential Facts About Primary-Progressive MS

Part I: Understanding Progression in MS | MSAA
Part I: Understanding Progression in MS | MSAA

Treatment Patterns and Unmet Need for Patients with Progressive Multiple  Sclerosis in the United States: Survey Results from 2016 to 2021 |  Neurology and Therapy
Treatment Patterns and Unmet Need for Patients with Progressive Multiple Sclerosis in the United States: Survey Results from 2016 to 2021 | Neurology and Therapy

Navigating Life with PPMS | MultipleSclerosis.net
Navigating Life with PPMS | MultipleSclerosis.net

Ocrevus May Delay by 7 Years PPMS Patients' Need for Wheelchair
Ocrevus May Delay by 7 Years PPMS Patients' Need for Wheelchair

Why I Feel Overlooked Living With a Rare Type of MS (PPMS)
Why I Feel Overlooked Living With a Rare Type of MS (PPMS)

MS Progression Chart: Stages of MS, Disability Scale, and More
MS Progression Chart: Stages of MS, Disability Scale, and More

Risk of requiring a wheelchair in primary progressive multiple sclerosis:  Data from the ORATORIO trial and the MSBase registry - Butzkueven - 2022 -  European Journal of Neurology - Wiley Online Library
Risk of requiring a wheelchair in primary progressive multiple sclerosis: Data from the ORATORIO trial and the MSBase registry - Butzkueven - 2022 - European Journal of Neurology - Wiley Online Library

DMTs may reduce risk for becoming wheelchair dependent in patients with PPMS
DMTs may reduce risk for becoming wheelchair dependent in patients with PPMS

PDF] Multiple sclerosis that is progressive from the time of onset:  clinical characteristics and progression of disability. | Semantic Scholar
PDF] Multiple sclerosis that is progressive from the time of onset: clinical characteristics and progression of disability. | Semantic Scholar

When Is the Best Time to Use an Automatic Wheelchair?
When Is the Best Time to Use an Automatic Wheelchair?

The natural history of primary progressive multiple sclerosis: insights  from the German NeuroTransData registry | BMC Neurology | Full Text
The natural history of primary progressive multiple sclerosis: insights from the German NeuroTransData registry | BMC Neurology | Full Text

Risk of requiring a wheelchair in primary progressive multiple sclerosis:  Data from the ORATORIO trial and the MSBase registry - Butzkueven - 2022 -  European Journal of Neurology - Wiley Online Library
Risk of requiring a wheelchair in primary progressive multiple sclerosis: Data from the ORATORIO trial and the MSBase registry - Butzkueven - 2022 - European Journal of Neurology - Wiley Online Library